HomeInsightsStock Comparison

Jagsonpal Pharmaceuticals Ltd vs Shree Ganesh Biotech India Ltd Stock Comparison

Jagsonpal Pharmaceuticals Ltd vs Shree Ganesh Biotech India Ltd Stock Comparison

Last Updated on: Aug 02, 2025

Key Highlights

  • The Latest Trading Price of Jagsonpal Pharmaceuticals Ltd is ₹ 271.15 as of 01 Aug 15:30.
  • The P/E Ratio of Jagsonpal Pharmaceuticals Ltd changed from 5.8 on March 2020 to 32.9 on March 2024 . This represents a CAGR of 41.50% over 5 yearsThe P/E Ratio of Shree Ganesh Biotech India Ltd changed from 1085 on March 2020 to 52.5 on March 2024 . This represents a CAGR of -45.43% over 5 years.
  • The Market Cap of Jagsonpal Pharmaceuticals Ltd changed from ₹ 45.72 crore on March 2020 to ₹ 737.06 crore on March 2024 . This represents a CAGR of 74.37% over 5 yearsThe Market Cap of Shree Ganesh Biotech India Ltd changed from ₹ 259.5 crore on March 2020 to ₹ 41.86 crore on March 2024 . This represents a CAGR of -30.57% over 5 years.
  • The revenue of Jagsonpal Pharmaceuticals Ltd for the Jun '25 is ₹ 78.44 crore as compare to the Mar '25 revenue of ₹ 61.33 crore. This represent the growth of 27.9% The revenue of Shree Ganesh Biotech India Ltd for the Jun '25 is ₹ 1.8 crore as compare to the Mar '25 revenue of ₹ 3.47 crore. This represent the decline of -48.13%.
  • The ebitda of Jagsonpal Pharmaceuticals Ltd for the Jun '25 is ₹ 17.04 crore as compare to the Mar '25 ebitda of ₹ 11.27 crore. This represent the growth of 51.2% The ebitda of Shree Ganesh Biotech India Ltd for the Jun '25 is ₹ 0.33 crore as compare to the Mar '25 ebitda of ₹ -0.95 crore. This represent the decline of -134%.
  • The net profit of Jagsonpal Pharmaceuticals Ltd changed from ₹ 7.48 crore to ₹ 10.8 crore over 9 quarters. This represents a CAGR of 17.73% The net profit of Shree Ganesh Biotech India Ltd changed from ₹ 0.15 crore to ₹ 0.33 crore over 9 quarters. This represents a CAGR of 41.97% .
  • The Dividend Payout of Jagsonpal Pharmaceuticals Ltd changed from 16.65 % on March 2020 to 58.86 % on March 2024 . This represents a CAGR of 28.73% over 5 yearsThe Dividend Payout of Shree Ganesh Biotech India Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Jagsonpal Pharmaceuticals Ltd

  • Promoted by Rajpal Singh Kochhar in August, 1978, Jagsonpal Pharmaceuticals Limited is engaged in the manufacture and marketing bulk drugs and pharmaceuticals at its plant at Faridabad in Haryana.
  • The Company has adopted the strategy of clubbing all its products in seven groups for effective marketing and reducing costs.
  • Simultaneously, it has geared up to set up an ultra modern multi-purpose basic drugs and formulation plant through its subsidiary, Jagsonpal Exports India Pvt Ltd. The company has a strategic alliance with Fidia Spa, Italy; and B Spofola, Czechoslovakia; to manufacture sophisticated drugs in India.
  • It has tied up with another Israel-based company, Makhteshim Chemical Works, for acquiring the marketing rights of an anti-oxidant product.
  • In 1994, the company has also promoted Aresco Financial Services, a new financial company.

About Shree Ganesh Biotech India Ltd

  • Shree Ganesh Biotech India Limited was incorporated on September 2, 1982, as 'S.P. Commercial Co. Limited' under the Registrar of Companies, West Bengal.
  • The Company has got the Certificate of Commencement of Business on September 14, 1982 from the Registrar of Companies, West Bengal.
  • The Company was incorporated with an object to carry on the business of builders, Contractors and to deal in property and also to do investment and finance business. In 2010, pursuant to a Scheme of Amalgamation, Shree Ganesh Bio-Tech (India) Private Limited was merged with S.P. Commercial Co. Limited pursuant to the order of the Hon'ble High at Calcutta dated February 15, 2010.
  • The entire business of Shree Ganesh Bio-Tech (India) Private Limited consisting of trading and distribution of seeds were transferred to S.

Jagsonpal Pharmaceuticals Ltd News Hub

News

Jagsonpal Pharmaceuticals AGM scheduled

Jagsonpal Pharmaceuticals announced that the 45th Annual General Meeting(AGM) of the compa...

Read more

28 Jul 2025 11:09

News

Jagsonpal Pharmaceuticals to announce Quarterly Result

Jagsonpal Pharmaceuticals will hold a meeting of the Board of Directors of the Company on ...

Read more

23 Jul 2025 15:57

News

Jagsonpal Pharmaceuticals allots 53,000 equity shares under ESOP

Jagsonpal Pharmaceuticals has allotted 53,000 equity shares under ESOP on 11 June 2025. Wi...

Read more

11 Jun 2025 18:15

News

Board of Jagsonpal Pharmaceuticals recommends final dividend

Jagsonpal Pharmaceuticals announced that the Board of Directors of the Company at its meet...

Read more

07 May 2025 09:28

News

Jagsonpal Pharmaceuticals to announce Quarterly Result

Jagsonpal Pharmaceuticals will hold a meeting of the Board of Directors of the Company on ...

Read more

30 Apr 2025 10:51

News

Jagsonpal Pharmaceuticals allots 39,850 equity shares under ESOP

Jagsonpal Pharmaceuticals has allotted 39,850 equity shares under ESOP. With this allotmen...

Read more

21 Apr 2025 14:14

Shree Ganesh Biotech India Ltd News Hub

News

Shree Ganesh Biotech India to conduct board meeting

Shree Ganesh Biotech India will hold a meeting of the Board of Directors of the Company on...

Read more

17 Jul 2025 10:12

News

Shree Ganesh Biotech India to convene board meeting

Shree Ganesh Biotech India will hold a meeting of the Board of Directors of the Company on...

Read more

13 May 2025 12:01

News

Shree Ganesh Biotech India to discuss results

Shree Ganesh Biotech India will hold a meeting of the Board of Directors of the Company on...

Read more

21 Jan 2025 10:34

News

Shree Ganesh Biotech India announces board meeting date

Shree Ganesh Biotech India will hold a meeting of the Board of Directors of the Company on...

Read more

17 Oct 2024 10:28

News

Shree Ganesh Biotech India to convene AGM

Shree Ganesh Biotech India announced that the Annual General Meeting (AGM) of the company ...

Read more

16 Sep 2024 10:34

News

Shree Ganesh Biotech India to conduct AGM

Shree Ganesh Biotech India announced that the Annual General Meeting (AGM) of the company ...

Read more

14 Sep 2024 17:42

SWOT Analysis Of Shree Ganesh Biotech India Ltd

Strength

2

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Jagsonpal Pharmaceuticals Ltd

Strength

2

S

Weakness

0

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Shree Ganesh Biotech India Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Jagsonpal Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Jagsonpal Pharmaceuticals Ltd and Shree Ganesh Biotech India Ltd

Which company has a larger market capitalization, Jagsonpal Pharmaceuticals Ltd or Shree Ganesh Biotech India Ltd?

Market cap of Jagsonpal Pharmaceuticals Ltd is 1,803 Cr while Market cap of Shree Ganesh Biotech India Ltd is 31 Cr

What are the key factors driving the stock performance of Jagsonpal Pharmaceuticals Ltd and Shree Ganesh Biotech India Ltd?

The stock performance of Jagsonpal Pharmaceuticals Ltd and Shree Ganesh Biotech India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Jagsonpal Pharmaceuticals Ltd and Shree Ganesh Biotech India Ltd?

As of August 2, 2025, the Jagsonpal Pharmaceuticals Ltd stock price is INR ₹271.15. On the other hand, Shree Ganesh Biotech India Ltd stock price is INR ₹0.79.

How do dividend payouts of Jagsonpal Pharmaceuticals Ltd and Shree Ganesh Biotech India Ltd compare?

To compare the dividend payouts of Jagsonpal Pharmaceuticals Ltd and Shree Ganesh Biotech India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions